Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Oct;29(10):2602.
doi: 10.1681/ASN.2018050517. Epub 2018 Aug 9.

Fibroblast Growth Factor-23 May Follow Cardiovascular Disease Rather than Causing It in Chronic Kidney Disease

Chenchen Zhou  1   2 , Changlin Mei  2 , Bing Dai  2 , Cheng Xue  3
Affiliations
Comment

Fibroblast Growth Factor-23 May Follow Cardiovascular Disease Rather than Causing It in Chronic Kidney Disease

Chenchen Zhou et al. J Am Soc Nephrol. 2018 Oct.
No abstract available

Keywords: cardiovascular disease; chronic kidney disease; fibroblast.

PubMed Disclaimer

Comment in

  • Authors' Reply.
    Herrington WG, Donovan K, Mihaylova B. Herrington WG, et al. J Am Soc Nephrol. 2018 Oct;29(10):2602-2603. doi: 10.1681/ASN.2018060612. Epub 2018 Jul 13. J Am Soc Nephrol. 2018. PMID: 30006418 Free PMC article. No abstract available.

Comment on

  • Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.
    Isakova T, Cai X, Lee J, Xie D, Wang X, Mehta R, Allen NB, Scialla JJ, Pencina MJ, Anderson AH, Talierco J, Chen J, Fischer MJ, Steigerwalt SP, Leonard MB, Hsu CY, de Boer IH, Kusek JW, Feldman HI, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Isakova T, et al. J Am Soc Nephrol. 2018 Feb;29(2):579-590. doi: 10.1681/ASN.2017070772. Epub 2017 Nov 22. J Am Soc Nephrol. 2018. PMID: 29167351 Free PMC article.

References

    1. Marthi A, Donovan K, Haynes R, Wheeler DC, Baigent C, Rooney CM, et al. .: Fibroblast growth factor-23 and risks of cardiovascular and noncardiovascular diseases: A meta-analysis. J Am Soc Nephrol 29: 579–590, 2018 - PMC - PubMed
    1. Xue C, Yang B, Zhou C, Dai B, Liu Y, Mao Z, et al. .: Fibroblast growth factor 23 predicts all-cause mortality in a dose-response fashion in pre-dialysis patients with chronic kidney disease. Am J Nephrol 45: 149–159, 2017 - PubMed
    1. Matsui I, Oka T, Kusunoki Y, Mori D, Hashimoto N, Matsumoto A, et al. .: Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23. Kidney Int 94: 60–71, 2018 - PubMed
    1. Hu MC, Shi M, Cho HJ, Adams-Huet B, Paek J, Hill K, et al. .: Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. J Am Soc Nephrol 26: 1290–1302, 2015 - PMC - PubMed
    1. Slavic S, Ford K, Modert M, Becirovic A, Handschuh S, Baierl A, et al. .: Genetic ablation of Fgf23 or Klotho does not modulate experimental heart hypertrophy induced by pressure overload. Sci Rep 7: 11298, 2017 - PMC - PubMed

Substances